Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DprE1 is a flavoenzyme essential for the biosynthesis of decaprenylphosphoryl-D-arabinose (DPA), a crucial precursor for arabinogalactan and lipoarabinomannan synthesis in mycobacteria, including *Mycobacterium tuberculosis*. As DPA is necessary for cell wall integrity, DprE1 is a validated drug target, and its inhibition leads to bacterial death.
Inhibition of decaprenylphosphoryl-β-D-ribose 2′-epimerase activity, leading to disruption of cell wall synthesis
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycolic acid biosynthesis enzyme DprE1.